SCHEMBL19477494

SCHEMBL19477494

C=Cc1ccc(Cl)nc1NC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
LRRK2 Q5S007 4/20 0.36
JAK2 O60674 1/20 0.36
TRIM58 Q8NG06 1/20 0.36
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MAP4K4 O95819 1/20 0.33
PGK1 P00558 1/20 0.33
ACVR2A P27037 1/20 0.32
TGFBR1 P36897 1/20 0.32
PDCD1 Q15116 3/20 0.32
CD274 Q9NZQ7 3/20 0.32
KDM4E B2RXH2 2/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24076841 0.81 CRHBP (0.33) CYP1A2CYP3A4CYP2C19CYP2D6CYP2C9
SCHEMBL20663170 0.77 TRIM58 (0.36) TRIM58CYP1A2CYP3A4CYP2C19ACVR2A
SCHEMBL23758188 0.75 ALDH1A1 (0.38) ALDH1A1CYP3A4CYP2C19HSD17B10KDM4E
SCHEMBL25523664 0.74 TRIM58 (0.34) TRIM58CYP1A2CYP3A4CYP2C19ACVR2A
SCHEMBL3139494 0.73 ALDH1A1 (0.44) ALDH1A1LRRK2JAK2ACVR2ATGFBR1
SCHEMBL25711816 0.73 NCF1 (0.43) ALDH1A1TRIM58TDP1KDM4ELMNA
SCHEMBL15596165 0.73 ALDH1A1 (0.39) ALDH1A1TDP1
SCHEMBL7969276 0.72 LCK (0.40) MAP4K4LMNAMEN1GAAKMT2A
SCHEMBL16261557 0.71 LRRK2 (0.37) ALDH1A1LRRK2JAK2CYP1A2CYP3A4
SCHEMBL1502908 0.69 SIRT2 (0.38) ALDH1A1LRRK2JAK2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017181177-A1 AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS AS EHMT1 AND EHMT2 INHIBITORS Epizyme, Inc. (US) 2017-10-19 WO disclosed